Perceptions and Practices of the Adult Population in Response to SARS-CoV-2 Pandemic in India
Abstract
Study Objective: To find the perceptions and behaviours of the general public in response to the novel coronavirus pandemic in India.
Design: An online survey was conducted during lockdown period of coronavirus pandemic.
Participants: 304 respondents participated in the survey during the lockdown period of 21 days.
Main Outcome Measures: Perceptions and behaviours of adult population to coronavirus infections and its prevention.
Result: The mean age of the respondents was 38.38±12.34 years. Most of the respondents believed that coronavirus was a contagious infection could be transmitted via direct body contact and droplets and majority 285 (93.8%) of the respondents were aware that coronavirus is a contagious infection. Nonetheless, perceived chance of infection was found by 284 (93.4%) respondents due to public transport, mass gatherings or crowds and through contaminated food or takeaways in only 94 (30.9%). Perceived efficacy of preventive measures was social distancing (77.3%), hand washing (75.3%) and wearing a mask (48%). It is interesting to note that some people were taking multivitamin, Unani immune modulator, homoeopathic and Hydroxychloroquine medicines as prophylaxis.
Conclusion: Coronavirus related perceptions and behaviours are crucial for designing preventive measures. Knowledge about the pandemic was high but misconceptions were also existed in the study group which need further improvement of appropriate IEC activities among Indian population.
How to cite this article:
Nazli T, Heena, Raheem A, Kishore J. Perceptions and Practices of the Adult Population in Response to SARS-CoV-2 Pandemic in India. Epidem Int 2020; 5(2): 10-16.
DOI: https://doi.org/10.24321/2455.7048.202011
References
Worldometer [cited 13 April 2020]. Available from: https://www.worldometers.info/coronavirus/.
65% Indians Think Covid-19 Won’t Affect India as it’s a Warm Country, Survey Reveals [Internet]. News18.
[cited 12 April 2020]. Available from: https://www.news18.com/news/buzz/65-indians-think-covid-
-wont-affect-india-as-its-a-warm-country-surveyreveals-2544649.html.
Advice for public [Internet]. Who.int. 2020 [cited 12 April 2020]. Available from: https://www.who.int/
emergencies/diseases/novel-coronavirus-2019/advicefor-public.
Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020
[cited 12 April 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/
diy-cloth-face-coverings.html.
Who.int. 2020 [cited 12 April 2020]. Available from: https://www.who.int/docs/default-source/
coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2.
Myth busters [Internet]. Who.int. 2020 [cited 12 April 2020]. Available from: https://www.who.int/
emergencies/diseases/novel-coronavirus-2019/advicefor-public/myth-busters.
Advice for public [Internet]. Who.int. 2020 [cited 12 April 2020]. Available from: https://www.who.int/
emergencies/diseases/novel-coronavirus-2019/advicefor-public.
Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020
[cited 12 April 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/
diy-cloth-face-coverings.html.
Rajagopal, D. 2020. Covid-19: Forget Healing Touch, Pharma Gets It Rough. [online] The Economic Times.
Available at: <https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/
covid-19-forget-healing-touch-pharma-gets-it-rough/articleshow/74820419.cms> [Accessed 12 April 2020].
The Economic Times. 2020. Coronavirus: ICMR Recommends Hydroxychloroquine For High-
Risk Population. [online] Available at: <https://economictimes.indiatimes.com/industry/healthcare/
biotech/pharmaceuticals/indias-covid-task-forcerecommends-hydroxychloroquine-for-high-riskpatients-
with-strict-riders/articleshow/74774540.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst> [Accessed 12 April 2020].
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P et al. In Vitro Antiviral Activity and Projection of Optimized Dosing
Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2). Clinical Infectious Diseases 2020.
Singh A, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and
other developing countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(3):
-246.
Clinical Trials Registry - India (CTRI) [Internet]. Ctri.nic.in. 2020 [cited 12 April 2020]. Available from: http://
ctri.nic.in/Clinicaltrials/login.php.
ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2020 [cited 12 April 2020]. Available from: https://
clinicaltrials.gov/.
CDC Works 24/7 [Internet]. Centers for Disease Control and Prevention. 2020 [cited 12 April 2020]. Available
from: https://www.cdc.gov/.
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved Drug Ivermectin inhibits the replication
of SARS-CoV-2 in vitro, Antiviral Research, https://doi.org/10.1016/j.antiviral.2020.104787.
